The spread of monkeypox has boosted the shares of a Danish biotech company called Bavarian Nordic A/S, which say it’s the only one to make a vaccine approved for the viral infection.
According to CEO Paul Chaplin, Bavarian Nordic has already recieved requests from dozens of countries who are seeking the vaccine and confimred the company had secured a contract to supply the shot to an unnamed country in Europe.
“Monkeypox” – who could have seen that coming?
Well take a look at who funded Bavarian Nordic…. none other than Dr Anthony Fauci
And look at some of the shareholers…notably Vanguard and BlackRock.
Dr Sam Bailey reports: As with COVID-19 it appears that other parties have also been eagerly awaiting a market such a “pandemic” would present. Likewise, these fortune-tellers were preparing vaccines to go where no vaccine had gone before. In this case the biotech company Bavarian Nordic gained approval from the FDA in 2019 to market JYNNEOS, a smallpox and monkeypox vaccine. Other health authorities were also primed to react to a previously rare condition that has been of no concern for their nations…until now apparently. For example, on May 20, 2022, the UK Health Security Agency published a document titled, “Recommendations for the use of pre and post exposure vaccination during a monkeypox incident.” Like COVID-19, it’s starting to feel like all roads lead to vaccines again…
So now that the scene has been set we can get into the “science” of monkeypox starting with an official description of the alleged viral disease. The CDC states that, “Monkeypox was first discovered in 1958 when two outbreaks of a pox-like disease occurred in colonies of monkeys kept for research, hence the name ‘monkeypox.’ The first human case of monkeypox was recorded in 1970 in the Democratic Republic of Congo.” They go on to state that, “in humans, the symptoms of monkeypox are similar to but milder than the symptoms of smallpox.” The illness is said to be flu-like with the addition of lymph node swelling and then development of a rash, and then lesions that progress from macules to vesicles to scabs.
In terms of the lethality of monkeypox, the CDC state that, “in Africa, monkeypox has been shown to cause death in as many as 1 in 10 persons who contract the disease.” This 10% fatality rate has already stoked the fear narrative and was also used as the case fatality rate in the NTI’s monkeypox pipe dream. It should be noted that historically monkeypox has been virtually unheard of in first world countries and the rare cases are usually in people that have recently arrived from Africa.
Continue reading here
No comments:
Post a Comment